Étiquette : bactérie

Cannabidiol (CBD) repurposing as antibacterial: promising therapy of 1 CBD plus polymyxin B against superbugs, Nathália Abichabki et al.,,

Cannabidiol (CBD) repurposing as antibacterial: promising therapy of 1 CBD plus polymyxin B against superbugs Nathália Abichabki, Luísa V. Zacharias, Natália C. Moreira, Fernando Bellissimo-Rodrigues, Fernanda L. Moreira, Jhohann R. L. Benzi1, Tânia M. C. Ogasawara, Joseane C.  Ferreira, Leonardo R. L. Pereira, Gilberto Ú. L. Braga, Camila M. Ribeiro, Fernando R.  Pavan, Antonio W. Zuardi, Jaime E. C. Hallak, José A. S. Crippa, Vera L. Lanchote,  Rafael Cantón, Ana Lúcia C. Darini, Leonardo N. Andrade bioRxiv preprint, 2021 doi : 10.1101/2021.04.12.439341   Abstract : Multidrug-resistant (MDR) and extensively drug-resistant (XDR) bacteria are a major worldwide public health problem. In the last decades, resistance to [...]

Lire la suite

Scientists mass-produce ‘magic mushroom’ active ingredient from bacteria, ZEM Science, 2019

Scientists mass-produce 'magic mushroom' active ingredient from bacteria The study shows that psilocybin can be produced in a sustainable manner. https://www.zmescience.com/medicine/scientists-mass-produce-magic-mushroom-active-ingredient-from-bacteria/ byTibi Puiu October 3, 2019 Psilocybin, the active psychoactive compound found in specific mushrooms, is a promising drug that can be used to treat depression, anxiety, addiction, and post-traumatic stress disorder. Looking towards the future, researchers at Miami University have used genetic engineering to coax harmless E. coli bacteria to produce psilocybin. Psilocybe semilanceata. Credit: Pixabay. The mushrooms that produce psilocybin, such as Psilocybe cubensis, are not particularly expensive or difficult to grow. However, they do take up a lot of space and require many [...]

Lire la suite